Haematologica
(Oct 2024)
HDAC6 inhibitors sensitize resistant t(11;14) multiple myeloma cells to a combination of bortezomib and BH3 mimetics
- Cristina Florean,
- Manon Lernoux,
- Anne Lorant,
- Helene Losson,
- Guy Bormans,
- Michael Schnekenburger,
- Marc Diederich
Affiliations
- Cristina Florean
- Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
- Manon Lernoux
- Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
- Anne Lorant
- Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
- Helene Losson
- Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
- Guy Bormans
- Laboratory for Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven
- Michael Schnekenburger
- Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg
- Marc Diederich
- Research Institute of Pharmaceutical Sciences and Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul
- DOI
-
https://doi.org/10.3324/haematol.2024.286279
- Journal volume & issue
-
Vol. 999,
no. 1
WeChat QR code
